Here are three key points:
1. Under the agreement, Progenerative Medical possesses exclusive, global rights to Kinetic Concepts’ intellectual property and preclinical product development portfolio.
2. Kinetic Concepts’ portfolio includes negative pressure therapies for spine and general orthopedics.
3. Progenerative Medical may not develop and commercialize these negative pressure therapies.
“This agreement provides the foundation for our team, rich in talent and experience, to translate the very promising results seen in extensive preclinical studies into products with the potential to significantly improve clinical outcomes and patient satisfaction in orthopedic and spinal surgeries,” said James Poser, PhD, CEO and co-founder, Progenerative Medical.
More articles on devices:
Dr. Nicholas Theodore to present on the Neuro-Spinal Scaffold at 2016 Congress of Neurological Surgeons Annual Meeting: 4 highlights
Medovex partners with M.Fast Technologies for DenerveX System distribution in Israel: 5 notes
First surgical procedures with Implanet’s Jazz Lock reap success: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
